Processing your request


please wait...

Case Page

 

Case Status:    ONGOING    
On or around 07/22/2019 (Ongoing date of last review)

Filing Date: July 22, 2019

According to the Complaint, Medidata leads the digital transformation of life science, with the world’s most used
platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by top-ranked industry experts, the Company helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk, and optimize outcomes.

This action stems from a proposed transaction announced on June 12, 2019, pursuant to which Medidata Solutions, Inc. will be acquired by Dassault Systèmes SE.

On June 11, 2019, Medidata’s Board of Directors caused the Company to enter into an agreement and plan of merger with Dassault. Pursuant to the terms of the Merger Agreement, Medidata’s stockholders will receive $92.25 in cash for each share of Medidata common stock they own.

On July 19, 2019, Defendants filed a proxy statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction, which scheduled a stockholder vote on the Proposed Transaction for August 16, 2019. The Complaint alleges that the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.

COMPANY INFORMATION:

Sector: Services
Industry: Communications Services
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: MDSO
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 19-CV-01361
JUDGE: Hon. Richard G. Andrews
DATE FILED: 07/22/2019
CLASS PERIOD START: 06/12/2019
CLASS PERIOD END: 07/22/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Rigrodsky & Long, P.A.
    919 N. Market Street, Suite 980, Rigrodsky & Long, P.A., DE 19803
    302.295.5310 302.295.5310 · info@rigrodskylong.com
  2. RM Law, P.C.
    1055 Westlakes Drive, Suite 3112, RM Law, P.C., PA 19312
    (484) 324-6800 ·
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available